Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Hospital for Children and Adolescents, Finland |
---|---|
Information provided by: | Hospital for Children and Adolescents, Finland |
ClinicalTrials.gov Identifier: | NCT00623116 |
Objective is to characterize epidemiology, clinical and genetic features of Kallmann syndrome in Finland.
Condition | Intervention |
---|---|
Kallmann Syndrome |
Drug: Short withdrawal of testosterone, gonadotropins or estrogenic compounds (see below) |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
Official Title: | Kallmann Syndrome in Finland |
Estimated Enrollment: | 50 |
Study Start Date: | December 2007 |
Estimated Study Completion Date: | December 2025 |
Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
Kallmann syndrome is comprised of idiopathic hypogonadotropic hypogonadism and anosmia (inability to smell). Associated phenotypes may include cryptorchidism, microphallus, bone deformations, mirror movements, hearing loss and infertility. Objective is to characterize epidemiology, clinical and genetic features of Kallmann syndrome in Finland.
Ages Eligible for Study: | 15 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Finland | |
Hospital for Children and Adolescents, Helsinki University Central Hospital | |
Helsinki, Finland, 00029 HUCH |
Study Director: | Taneli J Raivio, MD PhD | Hospital for Children and Adolescents, Helsinki University Central Hospital |
Responsible Party: | Hospital for Children and Adolescents, Helsinki University Hospital ( Taneli Raivio, MD, Ph D ) |
Study ID Numbers: | 231408, 286/E7/2007 |
Study First Received: | January 11, 2008 |
Last Updated: | February 13, 2008 |
ClinicalTrials.gov Identifier: | NCT00623116 |
Health Authority: | Finland: Ethics Committee |
Kallmann Syndrome hypogonadotropic hypogonadism |
Gonadal Disorders Nervous System Malformations Estradiol valerate Endocrine System Diseases Kallmann Syndrome Septo-optic dysplasia Estradiol 17 beta-cypionate Methyltestosterone Chorionic Gonadotropin Sex Differentiation Disorders Estradiol |
Testosterone 17 beta-cypionate Testosterone Hypogonadism Urogenital Abnormalities Genetic Diseases, Inborn Estradiol 3-benzoate Endocrinopathy Polyestradiol phosphate Congenital Abnormalities Estrone Septo-Optic Dysplasia |
Pathologic Processes Disease Syndrome Physiological Effects of Drugs Nervous System Diseases |
Hormones, Hormone Substitutes, and Hormone Antagonists Hormones Pharmacologic Actions Androgens |